Zymeworks, Inc. (ZYME)
25.15
-0.81
(-3.12%)
USD |
NASDAQ |
Oct 02, 16:00
25.01
-0.14
(-0.56%)
After-Hours: 20:00
Zymeworks Profit Margin (Quarterly) : -980.8% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -980.8% |
| March 31, 2026 | -1.83K% |
| December 31, 2025 | -1.64K% |
| September 30, 2025 | -70.99% |
| June 30, 2025 | 4.76% |
| March 31, 2025 | -83.50% |
| December 31, 2024 | -75.75% |
| September 30, 2024 | -186.6% |
| June 30, 2024 | -195.8% |
| March 31, 2024 | -315.6% |
| December 31, 2023 | -85.56% |
| September 30, 2023 | -173.8% |
| June 30, 2023 | -730.5% |
| March 31, 2023 | -68.45% |
| December 31, 2022 | 76.88% |
| September 30, 2022 | -1.82K% |
| June 30, 2022 | -1.19K% |
| March 31, 2022 | -3.79K% |
| December 31, 2021 | -197.0% |
| September 30, 2021 | -1.38K% |
| June 30, 2021 | -3.81K% |
| March 31, 2021 | -6.92K% |
| December 31, 2020 | -241.7% |
| September 30, 2020 | -2.75K% |
| June 30, 2020 | -315.2% |
| Date | Value |
|---|---|
| March 31, 2020 | -376.5% |
| December 31, 2019 | -3.85K% |
| September 30, 2019 | -387.7% |
| June 30, 2019 | -368.9% |
| March 31, 2019 | -114.4% |
| December 31, 2018 | 32.06% |
| September 30, 2018 | -912.9% |
| June 30, 2018 | -26.70% |
| March 31, 2018 | -53.01K% |
| December 31, 2017 | 65.37% |
| September 30, 2017 | -13.65K% |
| June 30, 2017 | -817.3% |
| March 31, 2017 | -6.92K% |
| December 31, 2016 | -505.2% |
| September 30, 2016 | -570.8% |
| June 30, 2016 | -117.0% |
| March 31, 2016 | -1.04K% |
| December 31, 2015 | -552.4% |
| September 30, 2015 | -1.71K% |
| June 30, 2015 | -114.2% |
| March 31, 2015 | -22.68% |
| December 31, 2014 | -1.41K% |
| September 30, 2014 | -1.94K% |
| June 30, 2014 | -443.6% |
| March 31, 2014 | -571.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 21.21% |
| Aprea Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.26% |
| Return on Assets | -36.99% |
| Return on Invested Capital | -42.73% |
| Gross Profit Margin (Quarterly) | 57.43% |
| Operating Margin (Quarterly) | -919.0% |
| Return on Net Operating Assets | -281.4% |